Epigenetic modification of miR-10a regulates renal damage by targeting CREB1 in type 2 diabetes mellitus

Toxicology and Applied Pharmacology

Volumn 306, Issue , 2016, Pages 134-143

  Shan, Qun ^a   Zheng, Guihong ^a   Zhu, Aihua ^a   Cao, Li ^a   Lu, Jun ^a   Wu, Dongmei ^a   Zhang, ZiFeng ^a   Fan, Shaohua ^a   Sun, Chunhui ^a   Hu, Bin ^a   Zheng, Yuanlin ^a  

^a JIANGSU NORMAL UNIVERSITY   (China)

Author keywords

CREB1; HDAC3; Kidney damage; miR 10a; Type 2 diabetes

Indexed keywords

ALBUMIN; CREATININE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FIBRONECTIN; HISTONE DEACETYLASE 3; MICRORNA; MICRORNA 10A; STREPTOZOCIN; UNCLASSIFIED DRUG; CREB1 PROTEIN, MOUSE; HISTONE DEACETYLASE; MIRN10 MICRORNA, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GENE SILENCING; GENE TARGETING; GENETIC REGULATION; IN VITRO STUDY; IN VIVO STUDY; INSULIN TOLERANCE TEST; KIDNEY INJURY; KIDNEY PARENCHYMA; LENTIVIRINAE; LIPID DIET; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN EXPRESSION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; URINE LEVEL; ANIMAL; EXPERIMENTAL DIABETES MELLITUS; GENETIC EPIGENESIS; GENETICS; INSTITUTE FOR CANCER RESEARCH MOUSE; KIDNEY; KIDNEY DISEASE; MALE; METABOLISM; PATHOLOGY;

ANIMALS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; EPIGENESIS, GENETIC; FIBRONECTINS; HISTONE DEACETYLASES; KIDNEY; KIDNEY DISEASES; MALE; MICE, INBRED ICR; MICRORNAS;

EID: 84989318880     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2016.06.010     Document Type: Article

References (43)

1. Abdolmaleky, H.M., Cheng, K.H., Faraone, S.V., Wilcox, M., Glatt, S.J., Gao, F., Smith, C.L., Shafa, R., Aeali, B., Carnevale, J., Pan, H., Papageorgis, P., Ponte, J.F., Sivaraman, V., Tsuang, M.T., Thiagalingam, S., Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum. Mol. Genet. 15 (2006), 3132–3145.
2. Advani, A., Huang, Q., Thai, K., Advani, S.L., White, K.E., Kelly, D.J., Yuen, D.A., Connelly, K.A., Marsden, P.A., Gilbert, R.E., Long-term administration of the histone deacetylase inhibitor vorinostat attenuates renal injury in experimental diabetes through an endothelial nitric oxide synthase-dependent mechanism. Am. J. Pathol. 178 (2011), 2205–2214.
3. Ahad, A., Ganai, A.A., Mujeeb, M., Siddiqui, W.A., Chrysin, an anti-inflammatory molecule, abrogates renal dysfunction in type 2 diabetic rats. Toxicol. Appl. Pharmacol. 279 (2014), 1–7.
4. Beuvink, I., Kolb, F.A., Budach, W., Garnier, A., Lange, J., Natt, F., Dengler, U., Hall, J., Filipowicz, W., Weiler, J., A novel microarray approach reveals new tissue-specific signatures of known and predicted mammalian microRNAs. Nucleic Acids Res., 35, 2007, e52.
5. Buurman, R., Gurlevik, E., Schaffer, V., Eilers, M., Sandbothe, M., Kreipe, H., Wilkens, L., Schlegelberger, B., Kuhnel, F., Skawran, B., Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells. Gastroenterology 143:811–820 (2012), e811–e815.
6. Chen, Y.Q., Wang, X.X., Yao, X.M., Zhang, D.L., Yang, X.F., Tian, S.F., Wang, N.S., Abated microRNA-195 expression protected mesangial cells from apoptosis in early diabetic renal injury in mice. J. Nephrol. 25 (2012), 566–576.
7. Crepin, D., Benomar, Y., Riffault, L., Amine, H., Gertler, A., Taouis, M., The over-expression of miR-200a in the hypothalamus of ob/ob mice is linked to leptin and insulin signaling impairment. Mol. Cell. Endocrinol. 384 (2014), 1–11.
8. Danda, R.S., Habiba, N.M., Rincon-Choles, H., Bhandari, B.K., Barnes, J.L., Abboud, H.E., Pergola, P.E., Kidney involvement in a nongenetic rat model of type 2 diabetes. Kidney Int. 68 (2005), 2562–2571.
9. Ebert, M.S., Neilson, J.R., Sharp, P.A., MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat. Methods 4 (2007), 721–726.
10. Fang, Y., Shi, C., Manduchi, E., Civelek, M., Davies, P.F., MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 13450–13455.
11. Fu, X., Dong, B., Tian, Y., Lefebvre, P., Meng, Z., Wang, X., Pattou, F., Han, W., Wang, X., Lou, F., Jove, R., Staels, B., Moore, D.D., Huang, W., MicroRNA-26a regulates insulin sensitivity and metabolism of glucose and lipids. J. Clin. Invest. 125 (2015), 2497–2509.
12. Gaikwad, A.B., Gupta, J., Tikoo, K., Epigenetic changes and alteration of Fbn1 and Col3A1 gene expression under hyperglycaemic and hyperinsulinaemic conditions. Biochem. J. 432 (2010), 333–341.
13. Gao, Y., Zhang, M., Wu, T., Xu, M., Cai, H., Zhang, Z., Effects of D-pinitol on insulin resistance through the PI3K/Akt signaling pathway in type 2 diabetes mellitus rats. J. Agric. Food Chem. 63 (2015), 6019–6026.
14. Gilbert, R.E., Huang, Q., Thai, K., Advani, S.L., Lee, K., Yuen, D.A., Connelly, K.A., Advani, A., Histone deacetylase inhibition attenuates diabetes-associated kidney growth: potential role for epigenetic modification of the epidermal growth factor receptor. Kidney Int. 79 (2011), 1312–1321.
15. Hergenreider, E., Heydt, S., Tréguer, K., Boettger, T., Horrevoets, A.J., Zeiher, A.M., Scheffer, M.P., Frangakis, A.S., Yin, X., Mayr, M., Braun, T., Urbich, C., Boon, R.A., Dimmeler, S., Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat. Cell Biol. 14 (2012), 249–256.
16. Kato, M., Zhang, J., Wang, M., Lanting, L., Yuan, H., Rossi, J.J., Natarajan, R., MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 3432–3437.
17. Kato, M., Arce, L., Wang, M., Putta, S., Lanting, L., Natarajan, R., A microRNA circuit mediates transforming growth factor-beta1 autoregulation in renal glomerular mesangial cells. Kidney Int. 80 (2011), 358–368.
18. Kim, C., Lee, H., Cho, Y.M., Kwon, O.J., Kim, W., Lee, E.K., TNFalpha-induced miR-130 resulted in adipocyte dysfunction during obesity-related inflammation. FEBS Lett. 587 (2013), 3853–3858.
19. Kitamura, T., Connolly, K., Ruffino, L., Ajiki, T., Lueckgen, A., DiGiovanni, J., Kiguchi, K., The therapeutic effect of histone deacetylase inhibitor PCI-24781 on gallbladder carcinoma in BK5.erbB2 mice. J. Hepatol. 57 (2012), 84–91.
20. Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, A., Kamphorst, A.O., Landthaler, M., Lin, C., Socci, N.D., Hermida, L., Fulci, V., Chiaretti, S., Foa, R., Schliwka, J., Fuchs, U., Novosel, A., Muller, R.U., Schermer, B., Bissels, U., Inman, J., Phan, Q., Chien, M., Weir, D.B., Choksi, R., De Vita, G., Frezzetti, D., Trompeter, H.I., Hornung, V., Teng, G., Hartmann, G., Palkovits, M., Di Lauro, R., Wernet, P., Macino, G., Rogler, C.E., Nagle, J.W., Ju, J., Papavasiliou, F.N., Benzing, T., Lichter, P., Tam, W., Brownstein, M.J., Bosio, A., Borkhardt, A., Russo, J.J., Sander, C., Zavolan, M., Tuschl, T., A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129 (2007), 1401–1414.
21. Li, W., Zhang, M., Gu, J., Meng, Z.J., Zhao, L.C., Zheng, Y.N., Chen, L., Yang, G.L., Hypoglycemic effect of protopanaxadiol-type ginsenosides and compound K on type 2 diabetes mice induced by high-fat diet combining with streptozotocin via suppression of hepatic gluconeogenesis. Fitoterapia 83 (2012), 192–198.
22. Li, T., Yang, G.M., Zhu, Y., Wu, Y., Chen, X.Y., Lan, D., Tian, K.L., Liu, L.M., Diabetes and hyperlipidemia induce dysfunction of VSMCs: contribution of the metabolic inflammation/miRNA pathway. Am. J. Physiol. Endocrinol. Metab. 308 (2015), E257–E269.
23. Liu, W., Tang, F., Deng, Y., Li, X., Lan, T., Zhang, X., Huang, H., Liu, P., Berberine reduces fibronectin and collagen accumulation in rat glomerular mesangial cells cultured under high glucose condition. Mol. Cell. Biochem. 325 (2009), 99–105.
24. Mao, Y., Mohan, R., Zhang, S., Tang, X., MicroRNAs as pharmacological targets in diabetes. Pharmacol. Res. 75 (2013), 37–47.
25. Meerson, A., Traurig, M., Ossowski, V., Fleming, J.M., Mullins, M., Baier, L.J., Human adipose microRNA-221 is upregulated in obesity and affects fat metabolism downstream of leptin and TNF-alpha. Diabetologia 56 (2013), 1971–1979.
26. Pan, Z., Zhu, L.J., Li, Y.Q., Hao, L.Y., Yin, C., Yang, J.X., Guo, Y., Zhang, S., Hua, L., Xue, Z.Y., Zhang, H., Cao, J.L., Epigenetic modification of spinal miR-219 expression regulates chronic inflammation pain by targeting CaMKIIgamma. J. Neurosci. Off. J. Soc. Neurosci. 34 (2014), 9476–9483.
27. Pye, C., Elsherbiny, N.M., Ibrahim, A.S., Liou, G.I., Chadli, A., Al-Shabrawey, M., Elmarakby, A.A., Adenosine kinase inhibition protects the kidney against streptozotocin-induced diabetes through anti-inflammatory and anti-oxidant mechanisms. Pharmacol. Res. 85 (2014), 45–54.
28. Shan, Q., Zheng, Y., Lu, J., Zhang, Z., Wu, D., Fan, S., Hu, B., Cai, X., Cai, H., Liu, P., Liu, F., Purple sweet potato color ameliorates kidney damage via inhibiting oxidative stress mediated NLRP3 inflammasome activation in high fat diet mice. Food Chem. Toxicol. 69 (2014), 339–346.
29. Shi, C., Zhu, L., Chen, X., Gu, N., Chen, L., Zhu, L., Yang, L., Pang, L., Guo, X., Ji, C., Zhang, C., IL-6 and TNF-alpha induced obesity-related inflammatory response through transcriptional regulation of miR-146b. J. Interferon Cytokine Res. 34 (2014), 342–348.
30. Singh, L.P., Andy, J., Anyamale, V., Greene, K., Alexander, M., Crook, E.D., Hexosamine-induced fibronectin protein synthesis in mesangial cells is associated with increases in cAMP responsive element binding (CREB) phosphorylation and nuclear CREB: the involvement of protein kinases A and C. Diabetes 50 (2001), 2355–2362.
31. Skovso, S., Damgaard, J., Fels, J.J., Olsen, G.S., Wolf, X.A., Rolin, B., Holst, J.J., Effects of insulin therapy on weight gain and fat distribution in the HF/HS-STZ rat model of type 2 diabetes. Int. J. Obes. 39 (2015), 1531–1538.
32. Song, H., Smolen, P., Av-Ron, E., Baxter, D.A., Byrne, J.H., Dynamics of a minimal model of interlocked positive and negative feedback loops of transcriptional regulation by cAMP-response element binding proteins. Biophys. J. 92 (2007), 3407–3424.
33. Takahashi, P., Xavier, D.J., Evangelista, A.F., Manoel-Caetano, F.S., Macedo, C., Collares, C.V., Foss-Freitas, M.C., Foss, M.C., Rassi, D.M., Donadi, E.A., Passos, G.A., Sakamoto-Hojo, E.T., MicroRNA expression profiling and functional annotation analysis of their targets in patients with type 1 diabetes mellitus. Gene 539 (2014), 213–223.
34. Vatandoost, N., Amini, M., Iraj, B., Momenzadeh, S., Salehi, R., Dysregulated miR-103 and miR-143 expression in peripheral blood mononuclear cells from induced prediabetes and type 2 diabetes rats. Gene 572 (2015), 95–100.
35. Weiss, F.U., Marques, I.J., Woltering, J.M., Vlecken, D.H., Aghdassi, A., Partecke, L.I., Heidecke, C.D., Lerch, M.M., Bagowski, C.P., Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer. Gastroenterology 137:2136–2145 (2009), e2131–e2137.
36. Wu, J.H., Gao, Y., Ren, A.J., Zhao, S.H., Zhong, M., Peng, Y.J., Shen, W., Jing, M., Liu, L., Altered microRNA expression profiles in retinas with diabetic retinopathy. Ophthalmic Res. 47 (2012), 195–201.
37. Wu, H., Kong, L., Zhou, S., Cui, W., Xu, F., Luo, M., Li, X., Tan, Y., Miao, L., The role of microRNAs in diabetic nephropathy. J. Diabetes Res., 2014, 2014, 920134.
38. Zhang, Z., Luo, X., Ding, S., Chen, J., Chen, T., Chen, X., Zha, H., Yao, L., He, X., Peng, H., MicroRNA-451 regulates p38 MAPK signaling by targeting of Ywhaz and suppresses the mesangial hypertrophy in early diabetic nephropathy. FEBS Lett. 586 (2012), 20–26.
39. Zhang, L., He, S., Guo, S., Xie, W., Xin, R., Yu, H., Yang, F., Qiu, J., Zhang, D., Zhou, S., Zhang, K., Down-regulation of miR-34a alleviates mesangial proliferation in vitro and glomerular hypertrophy in early diabetic nephropathy mice by targeting GAS1. J. Diabetes Complicat. 28 (2014), 259–264.
40. Zhang, Y., Liu, J., Tian, X.Y., Wong, W.T., Chen, Y., Wang, L., Luo, J., Cheang, W.S., Lau, C.W., Kwan, K.M., Wang, N., Yao, X., Huang, Y., Inhibition of bone morphogenic protein 4 restores endothelial function in db/db diabetic mice. Arterioscler. Thromb. Vasc. Biol. 34 (2014), 152–159.
41. Zheng, H., Whitman, S.A., Wu, W., Wondrak, G.T., Wong, P.K., Fang, D., Zhang, D.D., Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy. Diabetes 60 (2011), 3055–3066.
42. Zhong, X., Chung, A.C., Chen, H.Y., Dong, Y., Meng, X.M., Li, R., Yang, W., Hou, F.F., Lan, H.Y., miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes. Diabetologia 56 (2013), 663–674.
43. Zhong, F., Chen, H., Wei, C., Zhang, W., Li, Z., Jain, M.K., Chuang, P.Y., Chen, H., Wang, Y., Mallipattu, S.K., He, J.C., Reduced Krϋpper–like factor 2 expression may aggravated the endothelial injury of diabetic nephropathy. Kidney Int. 87 (2015), 382–395.